🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.

Recruitingn/aAges 18 Years - anyAllJosep Rodes-Cabau
NCT05257954 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To assess the prevalence and severity of frailty in patients undergoing LAAC, as well as its association to peri-procedural and long-term outcomes and quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Transcatheter LAAC with any approved device * Age ≥18 years old Exclusion Criteria: * Unable to provide informed consent * Severe neuropsychiatric impairment
💊

What it tests

  • Not listed
📍

Where

1 site
IUCPQ_UL
Québec, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy